Literature DB >> 17577619

Helicobacter pylori infection, but not genetic polymorphism of CYP2E1, is highly prevalent in gastric cancer patients younger than 40 years.

Gotaro Masuda1, Akira Tokunaga, Takashi Shirakawa, Akiyoshi Togashi, Teruo Kiyama, Shunji Kato, Norio Matsukura, Hideki Bou, Masanori Watanabe, Takashi Tajiri.   

Abstract

BACKGROUND: Gastric cancers in young adults are thought to be associated with risk factors that include Helicobacter pylori infection and genetic polymorphism. The objective of this study was to elucidate the roles of these risk factors in patients younger than 40 years by analyzing clinicopathological data and H. pylori infection, and using molecular epidemiologic techniques.
METHODS: Clinicopathological features, the presence of H. pylori infection, endoscopic characteristics of gastritis, genetic polymorphism of P4502E1 (CYP2E1), and family history of cancer in patients with gastric cancer treated surgically at Nippon Medical School Hospital from 1991 to 2004 were analyzed, based on our medical database.
RESULTS: Gastric cancer in those younger than 40 years was characterized by a predominance of female patients with poorly differentiated adenocarcinoma who had undergone total gastrectomy with extended lymphadenectomy. H. pylori infection had a higher prevalence in patients with gastric cancer than in patients with normal endoscopic results or chronic gastritis, especially in those younger than 40 years (odds ratio, 13.7). Atrophic gastritis, nodular gastritis, and rugal hyperplastic gastritis were observed by endoscopy as H. pylori-associated gastritis. No difference in the incidence of either CYP2E1 genetic polymorphism or a family history of cancer was observed among different age groups.
CONCLUSION: Gastric cancer in patients younger than 40 years is closely associated with H. pylori infection, but not with genetic characteristics. Eradication therapy for H. pylori and endoscopic examination of H. pylori-positive young adults may be anticipated to be adopted as a strategy for the prevention and/or early detection of cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17577619     DOI: 10.1007/s10120-007-0414-y

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  35 in total

1.  Five cases of nodular gastritis and gastric cancer: a possible association between nodular gastritis and gastric cancer.

Authors:  M Miyamoto; K Haruma; M Yoshihara; M Sumioka; T Nishisaka; S Tanaka; K Inoue; K Chayama
Journal:  Dig Liver Dis       Date:  2002-11       Impact factor: 4.088

Review 2.  Cytochrome P450IIE1: roles in nitrosamine metabolism and mechanisms of regulation.

Authors:  C S Yang; J S Yoo; H Ishizaki; J Y Hong
Journal:  Drug Metab Rev       Date:  1990       Impact factor: 4.518

Review 3.  The Sydney System: endoscopic division. Endoscopic appearances in gastritis/duodenitis.

Authors:  G N Tytgat
Journal:  J Gastroenterol Hepatol       Date:  1991 May-Jun       Impact factor: 4.029

4.  Survival of young patients after gastrectomy for gastric cancer.

Authors:  Osvaldo Llanos; Jean Michel Butte; Fernando Crovari; Ignacio Duarte; Sergio Guzmán
Journal:  World J Surg       Date:  2006-01       Impact factor: 3.352

5.  Red meat intake, CYP2E1 genetic polymorphisms, and colorectal cancer risk.

Authors:  Loïc Le Marchand; Timothy Donlon; Ann Seifried; Lynne R Wilkens
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-10       Impact factor: 4.254

Review 6.  Long-term Helicobacter pylori infection and the development of atrophic gastritis and gastric cancer in Japan.

Authors:  Shin'ichi Takahashi
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

7.  Nodular gastritis in adults is caused by Helicobacter pylori infection.

Authors:  Masaki Miyamoto; Ken Haruma; Masaharu Yoshihara; Toru Hiyama; Masaaki Sumioka; Takashi Nishisaka; Shinji Tanaka; Kazuaki Chayama
Journal:  Dig Dis Sci       Date:  2003-05       Impact factor: 3.199

8.  Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.

Authors:  Benjamin Chun-Yu Wong; Shiu Kum Lam; Wai Man Wong; Jian Shun Chen; Ting Ting Zheng; Rui E Feng; Kam Chuen Lai; Wayne Hsing Cheng Hu; Siu Tsan Yuen; Suet Yi Leung; Daniel Yee Tak Fong; Joanna Ho; Chi Kong Ching; Jun Shi Chen
Journal:  JAMA       Date:  2004-01-14       Impact factor: 56.272

9.  Cytochrome P4502E1 (CYP2E1) genetic polymorphism in a case-control study of gastric cancer and liver disease.

Authors:  S Kato; M Onda; N Matsukura; A Tokunaga; T Tajiri; D Y Kim; H Tsuruta; N Matsuda; K Yamashita; P G Shields
Journal:  Pharmacogenetics       Date:  1995

10.  Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach.

Authors:  M J Blaser; G I Perez-Perez; H Kleanthous; T L Cover; R M Peek; P H Chyou; G N Stemmermann; A Nomura
Journal:  Cancer Res       Date:  1995-05-15       Impact factor: 12.701

View more
  11 in total

1.  Analysis of demographic characteristics in 3242 young age gastric cancer patients in Korea.

Authors:  Hye Won Chung; Sung Hoon Noh; Jong-Baeck Lim
Journal:  World J Gastroenterol       Date:  2010-01-14       Impact factor: 5.742

Review 2.  Helicobacter pylori and gastric cancer.

Authors:  Hidekazu Suzuki; Eisuke Iwasaki; Toshifumi Hibi
Journal:  Gastric Cancer       Date:  2009-06-27       Impact factor: 7.370

3.  Association between IL-4 -590C>T polymorphism and gastric cancer risk.

Authors:  Zihan Sun; Yuling Cui; Xiaohong Jin; Jing Pei
Journal:  Tumour Biol       Date:  2013-09-27

4.  NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma.

Authors:  Rongfeng Shi; Lei Wang; Tao Wang; Junfei Xu; Feiran Wang; Meirong Xu
Journal:  Med Oncol       Date:  2014-01-28       Impact factor: 3.064

5.  IL-1B -31T>C promoter polymorphism is associated with gastric stump cancer but not with early onset or conventional gastric cancers.

Authors:  R Sitarz; W W J de Leng; M Polak; F H M Morsink; O Bakker; W P Polkowski; R Maciejewski; G J A Offerhaus; A N Milne
Journal:  Virchows Arch       Date:  2008-08-08       Impact factor: 4.064

Review 6.  XRCC1 genetic polymorphism Arg399Gln and gastric cancer risk: A meta-analysis.

Authors:  Jian Geng; You-Wei Zhang; Gui-Chun Huang; Long-Bang Chen
Journal:  World J Gastroenterol       Date:  2008-11-21       Impact factor: 5.742

Review 7.  Association between hOGG1 polymorphism rs1052133 and gastric cancer.

Authors:  Dingding Zhang; Xiaoxin Guo; Jinliang Hu; Guangqun Zeng; Maomin Huang; Dandan Qi; Bo Gong
Journal:  Oncotarget       Date:  2017-05-23

Review 8.  Gastric cancer: epidemiology, prevention, classification, and treatment.

Authors:  Robert Sitarz; Małgorzata Skierucha; Jerzy Mielko; G Johan A Offerhaus; Ryszard Maciejewski; Wojciech P Polkowski
Journal:  Cancer Manag Res       Date:  2018-02-07       Impact factor: 3.989

9.  CYP2E1 RsaI/PstI polymorphism and gastric cancer susceptibility: meta-analyses based on 24 case-control studies.

Authors:  Wenlei Zhuo; Liang Zhang; Yan Wang; Junjun Ling; Bo Zhu; Zhengtang Chen
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

10.  Overexpression of S100A4 is closely associated with the progression and prognosis of gastric cancer in young patients.

Authors:  Hua Li; Ziquan Liu; Chuanxiang Xu; Yunyun Chen; Jianwei Zhang; Bo Cui; Xuewei Chen; Gaihong An; Xiaojun She; Hongtao Liu; Zifeng Jiang; Tianhui Wang
Journal:  Oncol Lett       Date:  2013-02-28       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.